A potential cure for type 1 diabetes has been identified by scientists in a new mouse study. In an animal study, researchers at Stanford School of Medicine discovered that resetting the immune system ...

A potential cure for type 1 diabetes has been identified by scientists in a new mouse study. In an animal study, researchers at Stanford School of Medicine discovered that resetting the immune system ...

AUS vs ENG Live Score, 1st Ashes Test Day 1: Mitchell Starc produced a sensational performance on day one of the first Ashes Test in Perth, claiming 7-58 to skittle England for a modest 172. On a ...

ReNew already has an operating portfolio of 717 MW of operational wind capacity and 60 MW of solar capacity spread over 10 sites in Andhra Pradesh. India’s solar photovoltaic (PV) module manufacturing ...

Eli Lilly is releasing new Phase 3 trial results Tuesday. Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Abstract: The parallel connection of Si IGBT/SiC MOSFETs is an important research topic to achieve the balance between cost and performance and to utilize the characteristics of each. In this study, ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with type 1 diabetes. When you purchase through links on our site, we may earn ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Obesity drugs were first approved to treat type ...

Veronica Paulus is a former STAT intern supported by the Harvard University Institute of Politics. GLP-1 drugs could treat more than just diabetes and obesity. They may also reduce migraine frequency.

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...